Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)
China · Delayed Price · Currency is CNY 7.72
+0.04 (0.52%)
Feb 3, 2026, 3:04 PM CST
SHE:000952 Revenue
Hubei Guangji Pharmaceutical had revenue of 144.91M CNY in the quarter ending September 30, 2025, a decrease of -12.57%. This brings the company's revenue in the last twelve months to 605.87M, down -10.57% year-over-year. In the year 2024, Hubei Guangji Pharmaceutical had annual revenue of 638.80M, down -13.42%.
Revenue (ttm)
605.87M
Revenue Growth
-10.57%
P/S Ratio
4.42
Revenue / Employee
433.38K
Employees
1,398
Market Cap
2.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 638.80M | -99.02M | -13.42% |
| Dec 31, 2023 | 737.82M | -59.82M | -7.50% |
| Jan 1, 2023 | 797.64M | 12.07M | 1.54% |
| Jan 1, 2022 | 785.57M | 97.40M | 14.15% |
| Dec 31, 2020 | 688.17M | -43.17M | -5.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Int'l Group | 33.54B |
| Zhejiang Zhenyuan Share | 2.67B |
| Shanghai Shenqi Pharmaceutical Investment Management | 1.88B |
| Chongqing Lummy Pharmaceutical | 771.02M |
| Hangzhou Minsheng Healthcare | 744.06M |
| Hangzhou Bio-Sincerity Pharma-Tech | 590.33M |
| Zhejiang Haisen Pharmaceutical | 510.33M |
| Shandong Keyuan Pharmaceutical | 435.52M |